Evidence map›Paper›PMID 36877431›Full record

Observational studyUpdates in surgery2023

The impact of COVID-19 pandemic on breast surgery in Italy: a multi-centric retrospective observational study.

R Sgarzani, G Macrì, A Gurrado, A Curcio, F De Lorenzi, V Galimberti, C Garusi, M Bocchiotti, M Roncella, F Rovera and 12 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Updates in surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 1 country.

R SgarzaniDipartimento DIMEC, Università Di Bologna, Via Massarenti 9, 40126, Bologna, Italy. rossella.sgarzani2@unibo.it.ORCID http://orcid.org/0000-0002-5543-8013
G MacrìU.O. Chirurgia Plastica, Policlinico Universitario Agostino Gemelli, Rome, Italy.
A GurradoUnit of Academic General Surgery "V. Bonomo", Department of Biomedical Sciences and Human Oncology, University of Bari, "A. Moro", Bari, Italy.
A CurcioChirurgia Senologica, AUSL Della Romagna, Forlì, Italy.
F De LorenziDepartment of Plastic Surgery, European Institute of Oncology, Milan, Italy.
V GalimbertiDepartment of Plastic Surgery, European Institute of Oncology, Milan, Italy.
C GarusiDepartment of Plastic Surgery, European Institute of Oncology, Milan, Italy.
M BocchiottiU.O. Chirurgia Plastica, Città Della Salute, Turin, Italy.
M RoncellaUOC Chirurgia Senologica, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
F RoveraASST SetteLaghi Varese, Università Degli Studi Dell'Insubria, Varese, Italy.
G CaputoU.O. Chirurgia Plastica, ASUFC, Udine, Italy.
A SgarellaU.O. Chirurgia Generale 1, IRCCS- Policlinico San Matteo, Pavia, Italy.
L Barone AdesiU.O. Chirurgia Plastica, Policlinico Universitario Agostino Gemelli, Rome, Italy.
D TerribileU.O. Chirurgia Plastica, Policlinico Universitario Agostino Gemelli, Rome, Italy.
R NonnisChirurgia Plastica, AOU Sassari, Sassari, Italy.
P FrittelliU.O. Chirurgia Senologica, Ospedale San Giovanni Calibita Fatebenefratelli Isola Tiberina, Rome, Italy.
B CagliU.O. Chirurgia Plastica, Campus Bio-Medico, Rome, Italy.
S TennaU.O. Chirurgia Plastica, Campus Bio-Medico, Rome, Italy.
I BaldelliU.O. Chirurgia Plastica, Ospedale San Martino, Genoa, Italy.
A CordovaU.O. Chirurgia Plastica, Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, Italy.
R EliaUnit of Academic Plastic Surgery, Department of Emergency and Organ Transplantation, University of Bari, "A. Moro", Bari, Italy.
M SalgarelloU.O. Chirurgia Plastica, Policlinico Universitario Agostino Gemelli, Rome, Italy.
Agostino Gemelli University Polyclinic · ITEuropean Institute of Oncology · ITUniversità Campus Bio-Medico · ITUniversity of Bari Aldo Moro · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Ospedaliera Universitaria Pisana · ITAzienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITAzienda Ospedaliero Universitaria di Sassari · ITAzienda Unità Sanitaria Locale Della Romagna · ITFatebenefratelli Hospital · ITOspedale Policlinico San Martino · ITOspedale Santa Maria della Misericordia di Udine · ITPoliclinico San Matteo Fondazione · ITUniversity of Bologna · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 pandemic had an impact on surgical activities. The aim of this multi-centric, retrospective study was to evaluate the impact of the COVID-19 pandemic on breast surgery. The patients who operated during the pre-pandemic year 2019 were compared to those operated in 2020. Fourteen Breast Care Units provided data on breast surgical procedures performed in 2020 and 2019: total number of breast-conserving surgery (BCS), number of 1st level oncoplastic breast surgery (OBS), number of 2nd level OBS; total number of mastectomies, mastectomies without reconstruction, mastectomies with a tissue expander, mastectomies with direct to implant (DTI) reconstruction, mastectomies with immediate flap reconstruction; total number of delayed reconstructions, number of expanders to implant reconstructions, number of delayed flap reconstructions. Overall 20.684 patients were included: 10.850 (52.5%) operated during 2019, and 9.834 (47.5%) during 2020. The overall number of breast oncologic surgical procedures in all centers in 2020 was 8.509, compared to 9.383 in 2019 (- 9%). BCS decreased by 744 cases (- 13%), the overall number of mastectomies decreased by 130 cases (- 3.5%); mastectomy-BCS ratio was 39-61% in 2019, and 42-58% in 2020. Regarding immediate reconstructive procedures mastectomies with DTI reconstruction increased by 166 cases (+ 15%) and mastectomies with immediate expander reconstruction decreased by 297 cases (- 20%). Breast-delayed reconstructive procedures in all centers in 2020 were 142 less than in 2019 (- 10%). The outburst of the COVID-19 pandemic in 2020 determined an implemented number of mastectomies compared to BCS, an implemented number of immediate breast reconstructions, mainly DTI, and a reduction of expander reconstruction.

Indexed as

Breast NeoplasmsCOVID-19MammaplastyFemaleHumansMastectomyPandemicsRetrospective StudiesBreast surgeryCOVID-19DTI reconstructionMastestomyPandemic

Identifiers

PMID36877431
PMCPMC9987352
OpenAlexW4323294321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.